Future Medicine India – Clinical Trials Clinical Trials Archives | Future Medicine India

Clinical Trials

bNAbs to stall HIV

Clinical trials testing a broadly neutralising antibody VRC01 have come out with the finding that the single agent could not significantly stall the transmission of HIV.

Read More..


Immuno-oncology (IO) therapeutics are driving a transformational change in cancer treatment, mobilising the patient’s immune system against their cancer, and aimed at reducing toxicities.

Dr Anju Gopan

Include men in breast cancer trials: US FDA

The USFDA has stressed the inclusion of male patients in the clinical trials of breast cancer, in a recently released draft guidance, Male Breast Cancer: Developing Drugs for Treatment. “Less than one percent of all breast cancer cases occur in men, but men are more likely to be diagnosed at an older age and have […]


Collagenase for corneal burns

Clinical studies of a novel approach utilising collagenase to treat chemical burns in the eye has commenced at L V Prasad Eye Institute in Hyderabad.


delaminid in prevention of MDR-TB

Alarge clinical trial to assess the efficacy of delamanid in preventing people from developing multidrug-resistant tuberculosis (MDR-TB) has commenced.


Aftermath of a drug ban

The Drug Controller General of India (DCGI) banned the production of the painkiller injectable diclofenac sodium 75 mg/ml sold under the brand name Voveran on July 4, 2018.

Indian doctors endorse TAILORx finding on breast cancer vs chemo

Senior oncologists in India have strongly endorsed the breakthrough finding of the Trial Assigning Individualized Options for Treatment (TAILORx) conducted by United States National Cancer Institute (NCI) and ECOG-ACRIN Cancer Research Group.